APO Research

APO RESEARCH · REPORT

Ketoprofen

Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.

Product & engineering

Understand the product.

Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.

In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).

Selected research

Market Outlook & Growth Opportunities

Global Ketoprofen Market Outlook and Growth Opportunities 2026

Market perspective

Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.

In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).

China is the largest Ketoprofen market with about 68% market share. Europe is follower, accounting for about 18% market share.

Read the full market overview

The key players are SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Hubei Xunda etc. Top 3 companies occupied about 83% market share.

This report provides an overview of the global Ketoprofen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ketoprofen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ketoprofen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketoprofen market size, projected growth trends, production technologies, key applications, and end-use industries.

Ketoprofen Segment by Company

SANOFI-Aventis

Boehringer-Ingelheim

BEC

Zhejiang Jiuzhou

Hubei Xunda

Ketoprofen Segment by Type

Ketoprofen above 99.5%

Ketoprofen below 99.5%

Ketoprofen Segment by Application

Ketoprofen Tablets

Ketoprofen Capsules

Ketoprofen Gel

Others

Ketoprofen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ketoprofen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ketoprofen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ketoprofen significant trends, drivers, influence factors in global and regions.

6. To analyze Ketoprofen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketoprofen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketoprofen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketoprofen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ketoprofen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ketoprofen industry.

Chapter 3: Detailed analysis of Ketoprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ketoprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ketoprofen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ketoprofen Industry Trends Table 2. Ketoprofen Industry Drivers Table 3. Ketoprofen Industry Opportunities and Challenges Table 4. Ketoprofen Industry Restraints Table 5. Global Ketoprofen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ketoprofen Revenue Share by Company (2021-2026) Table 7. Global Ketoprofen Sales Volume by Company (t) & (2021-2026) Table 8. Global Ketoprofen Sales Volume Share by Company (2021-2026) Table 9. Global Ketoprofen Average Price (USD/t) of Company (2021-2026) Table 10. Global Ketoprofen Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ketoprofen Key Company Manufacturing Base & Headquarters Table 12. Global Ketoprofen Company, Product Type & Application Table 13. Global Ketoprofen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ketoprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ketoprofen above 99.5% Table 18. Significant Companies of Ketoprofen below 99.5% Table 19. Global Ketoprofen Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Ketoprofen Sales Volume by Type (2021-2026) & (t) Table 21. Global Ketoprofen Sales Volume by Type (2027-2032) & (t) Table 22. Global Ketoprofen Sales Volume Share by Type (2021-2026) Table 23. Global Ketoprofen Sales Volume Share by Type (2027-2032) Table 24. Global Ketoprofen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ketoprofen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ketoprofen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ketoprofen Sales Value Share by Type (2021-2026) Table 28. Global Ketoprofen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Ketoprofen Tablets Table 30. Significant Companies of Ketoprofen Capsules Table 31. Significant Companies of Ketoprofen Gel Table 32. Significant Companies of Others Table 33. Global Ketoprofen Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Ketoprofen Sales Volume by Application (2021-2026) & (t) Table 35. Global Ketoprofen Sales Volume by Application (2027-2032) & (t) Table 36. Global Ketoprofen Sales Volume Share by Application (2021-2026) Table 37. Global Ketoprofen Sales Volume Share by Application (2027-2032) Table 38. Global Ketoprofen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ketoprofen Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ketoprofen Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ketoprofen Sales Value Share by Application (2021-2026) Table 42. Global Ketoprofen Sales Value Share by Application (2027-2032) Table 43. Global Ketoprofen Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Ketoprofen Sales by Region (2021-2026) & (t) Table 45. Global Ketoprofen Sales Market Share by Region (2021-2026) Table 46. Global Ketoprofen Sales by Region (2027-2032) & (t) Table 47. Global Ketoprofen Sales Market Share by Region (2027-2032) Table 48. Global Ketoprofen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ketoprofen Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ketoprofen Sales Value Share by Region (2021-2026) Table 51. Global Ketoprofen Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ketoprofen Sales Value Share by Region (2027-2032) Table 53. Global Ketoprofen Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Ketoprofen Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Ketoprofen Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Ketoprofen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ketoprofen Sales by Country (2021-2026) & (t) Table 58. Global Ketoprofen Sales Market Share by Country (2021-2026) Table 59. Global Ketoprofen Sales by Country (2027-2032) & (t) Table 60. Global Ketoprofen Sales Market Share by Country (2027-2032) Table 61. Global Ketoprofen Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ketoprofen Sales Value Market Share by Country (2021-2026) Table 63. Global Ketoprofen Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ketoprofen Sales Value Market Share by Country (2027-2032) Table 65. SANOFI-Aventis Company Information Table 66. SANOFI-Aventis Business Overview Table 67. SANOFI-Aventis Ketoprofen Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. SANOFI-Aventis Ketoprofen Product Portfolio Table 69. SANOFI-Aventis Recent Development Table 70. Boehringer-Ingelheim Company Information Table 71. Boehringer-Ingelheim Business Overview Table 72. Boehringer-Ingelheim Ketoprofen Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Boehringer-Ingelheim Ketoprofen Product Portfolio Table 74. Boehringer-Ingelheim Recent Development Table 75. BEC Company Information Table 76. BEC Business Overview Table 77. BEC Ketoprofen Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. BEC Ketoprofen Product Portfolio Table 79. BEC Recent Development Table 80. Zhejiang Jiuzhou Company Information Table 81. Zhejiang Jiuzhou Business Overview Table 82. Zhejiang Jiuzhou Ketoprofen Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Zhejiang Jiuzhou Ketoprofen Product Portfolio Table 84. Zhejiang Jiuzhou Recent Development Table 85. Hubei Xunda Company Information Table 86. Hubei Xunda Business Overview Table 87. Hubei Xunda Ketoprofen Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Hubei Xunda Ketoprofen Product Portfolio Table 89. Hubei Xunda Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Ketoprofen Distributors List Table 93. Ketoprofen Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Ketoprofen Product Image Figure 2. Global Ketoprofen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ketoprofen Sales (2021-2032) & (t) Figure 5. Global Ketoprofen Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Ketoprofen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ketoprofen above 99.5% Image Figure 10. Ketoprofen below 99.5% Image Figure 11. Global Ketoprofen Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Ketoprofen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ketoprofen Sales Volume Share by Type (2021-2032) Figure 14. Global Ketoprofen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ketoprofen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ketoprofen Sales Value Share by Type (2021-2032) Figure 17. Ketoprofen Tablets Image Figure 18. Ketoprofen Capsules Image Figure 19. Ketoprofen Gel Image Figure 20. Others Image Figure 21. Global Ketoprofen Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Ketoprofen Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ketoprofen Sales Volume Share by Application (2021-2032) Figure 24. Global Ketoprofen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ketoprofen Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ketoprofen Sales Value Share by Application (2021-2032) Figure 27. Global Ketoprofen Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Ketoprofen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ketoprofen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ketoprofen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ketoprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ketoprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ketoprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ketoprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ketoprofen Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ketoprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ketoprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ketoprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ketoprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ketoprofen Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ketoprofen Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Ketoprofen above 99.5%
  • Ketoprofen below 99.5%
Applications
  • Ketoprofen Tablets
  • Ketoprofen Capsules
  • Ketoprofen Gel
  • Others
Companies covered
  • SANOFI-Aventis
  • Boehringer-Ingelheim
  • BEC
  • Zhejiang Jiuzhou
  • Hubei Xunda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ketoprofen Sales Value (2021-2032)
  4. 1.2.2 Global Ketoprofen Sales Volume (2021-2032)
  5. 1.2.3 Global Ketoprofen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ketoprofen Market Dynamics
  1. 2.1 Ketoprofen Industry Trends
  2. 2.2 Ketoprofen Industry Drivers
  3. 2.3 Ketoprofen Industry Opportunities and Challenges
  4. 2.4 Ketoprofen Industry Restraints
3 Ketoprofen Market by Company
  1. 3.1 Global Ketoprofen Company Revenue Ranking in 2025
  2. 3.2 Global Ketoprofen Revenue by Company (2021-2026)
  3. 3.3 Global Ketoprofen Sales Volume by Company (2021-2026)
  4. 3.4 Global Ketoprofen Average Price by Company (2021-2026)
  5. 3.5 Global Ketoprofen Company Ranking (2024-2026)
  6. 3.6 Global Ketoprofen Company Manufacturing Base and Headquarters
  7. 3.7 Global Ketoprofen Company Product Type and Application
  8. 3.8 Global Ketoprofen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ketoprofen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ketoprofen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ketoprofen Market by Type
  1. 4.1 Ketoprofen Type Introduction
  2. 4.1.1 Ketoprofen above 99.5%
  3. 4.1.2 Ketoprofen below 99.5%
  4. 4.2 Global Ketoprofen Sales Volume by Type
  5. 4.2.1 Global Ketoprofen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ketoprofen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ketoprofen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ketoprofen Sales Value by Type
  9. 4.3.1 Global Ketoprofen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ketoprofen Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ketoprofen Sales Value Share by Type (2021-2032)
5 Ketoprofen Market by Application
  1. 5.1 Ketoprofen Application Introduction
  2. 5.1.1 Ketoprofen Tablets
  3. 5.1.2 Ketoprofen Capsules
  4. 5.1.3 Ketoprofen Gel
  5. 5.1.4 Others
  6. 5.2 Global Ketoprofen Sales Volume by Application
  7. 5.2.1 Global Ketoprofen Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ketoprofen Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ketoprofen Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ketoprofen Sales Value by Application
  11. 5.3.1 Global Ketoprofen Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ketoprofen Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ketoprofen Sales Value Share by Application (2021-2032)
6 Ketoprofen Regional Sales and Value Analysis
  1. 6.1 Global Ketoprofen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ketoprofen Sales by Region (2021-2032)
  3. 6.2.1 Global Ketoprofen Sales by Region: 2021-2026
  4. 6.2.2 Global Ketoprofen Sales by Region (2027-2032)
  5. 6.3 Global Ketoprofen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ketoprofen Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ketoprofen Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ketoprofen Sales Value by Region (2027-2032)
  9. 6.5 Global Ketoprofen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ketoprofen Sales Value (2021-2032)
  12. 6.6.2 North America Ketoprofen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ketoprofen Sales Value (2021-2032)
  15. 6.7.2 Europe Ketoprofen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ketoprofen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ketoprofen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ketoprofen Sales Value (2021-2032)
  21. 6.9.2 South America Ketoprofen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ketoprofen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ketoprofen Sales Value Share by Country, 2025 VS 2032
7 Ketoprofen Country-level Sales and Value Analysis
  1. 7.1 Global Ketoprofen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ketoprofen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ketoprofen Sales by Country (2021-2032)
  4. 7.3.1 Global Ketoprofen Sales by Country (2021-2026)
  5. 7.3.2 Global Ketoprofen Sales by Country (2027-2032)
  6. 7.4 Global Ketoprofen Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ketoprofen Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ketoprofen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ketoprofen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ketoprofen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ketoprofen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ketoprofen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ketoprofen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ketoprofen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ketoprofen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ketoprofen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ketoprofen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ketoprofen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ketoprofen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ketoprofen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ketoprofen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ketoprofen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ketoprofen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ketoprofen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ketoprofen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ketoprofen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ketoprofen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ketoprofen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ketoprofen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ketoprofen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ketoprofen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ketoprofen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ketoprofen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ketoprofen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ketoprofen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ketoprofen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ketoprofen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ketoprofen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ketoprofen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ketoprofen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ketoprofen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ketoprofen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ketoprofen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ketoprofen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ketoprofen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ketoprofen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ketoprofen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ketoprofen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ketoprofen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ketoprofen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ketoprofen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ketoprofen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ketoprofen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ketoprofen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ketoprofen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ketoprofen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ketoprofen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ketoprofen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ketoprofen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ketoprofen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ketoprofen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ketoprofen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ketoprofen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ketoprofen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ketoprofen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ketoprofen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ketoprofen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ketoprofen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ketoprofen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ketoprofen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ketoprofen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ketoprofen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ketoprofen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ketoprofen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ketoprofen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ketoprofen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ketoprofen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ketoprofen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ketoprofen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ketoprofen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ketoprofen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ketoprofen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ketoprofen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ketoprofen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ketoprofen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ketoprofen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ketoprofen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ketoprofen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ketoprofen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ketoprofen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ketoprofen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ketoprofen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SANOFI-Aventis
  2. 8.1.1 SANOFI-Aventis Company Information
  3. 8.1.2 SANOFI-Aventis Business Overview
  4. 8.1.3 SANOFI-Aventis Ketoprofen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SANOFI-Aventis Ketoprofen Product Portfolio
  6. 8.1.5 SANOFI-Aventis Recent Developments
  7. 8.2 Boehringer-Ingelheim
  8. 8.2.1 Boehringer-Ingelheim Company Information
  9. 8.2.2 Boehringer-Ingelheim Business Overview
  10. 8.2.3 Boehringer-Ingelheim Ketoprofen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer-Ingelheim Ketoprofen Product Portfolio
  12. 8.2.5 Boehringer-Ingelheim Recent Developments
  13. 8.3 BEC
  14. 8.3.1 BEC Company Information
  15. 8.3.2 BEC Business Overview
  16. 8.3.3 BEC Ketoprofen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BEC Ketoprofen Product Portfolio
  18. 8.3.5 BEC Recent Developments
  19. 8.4 Zhejiang Jiuzhou
  20. 8.4.1 Zhejiang Jiuzhou Company Information
  21. 8.4.2 Zhejiang Jiuzhou Business Overview
  22. 8.4.3 Zhejiang Jiuzhou Ketoprofen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhejiang Jiuzhou Ketoprofen Product Portfolio
  24. 8.4.5 Zhejiang Jiuzhou Recent Developments
  25. 8.5 Hubei Xunda
  26. 8.5.1 Hubei Xunda Company Information
  27. 8.5.2 Hubei Xunda Business Overview
  28. 8.5.3 Hubei Xunda Ketoprofen Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Xunda Ketoprofen Product Portfolio
  30. 8.5.5 Hubei Xunda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ketoprofen Value Chain Analysis
  2. 9.1.1 Ketoprofen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ketoprofen Sales Mode & Process
  6. 9.2 Ketoprofen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ketoprofen Distributors
  9. 9.2.3 Ketoprofen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research